Advertisement
Screener

BRUKER CORPORATION (BRKR) Inventory Write-down

2.8 / 5 stars · 68/120 Roast Me

BRUKER CORPORATION Inventory Write-down

BRUKER CORPORATION (BRKR) reported Inventory Write-down of $30.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:InventoryWriteDown · last filed 2026-08-05

  • BRUKER CORPORATION inventory write-down for the quarter ending 2015-03-31 was $5.00M, a 34.21% decline year-over-year.
  • BRUKER CORPORATION inventory write-down for the quarter ending 2014-12-31 was $5.60M, a 35.63% decline year-over-year.
  • BRUKER CORPORATION inventory write-down for the quarter ending 2014-09-30 was $7.40M, a 7.50% decline year-over-year.
  • BRUKER CORPORATION inventory write-down for the quarter ending 2014-06-30 was $7.60M, a 7.32% decline year-over-year.
  • BRUKER CORPORATION inventory write-down for fiscal 2025 was $76.00M, a 26.25% increase from fiscal 2024.
  • BRUKER CORPORATION inventory write-down for fiscal 2024 was $60.20M, a 210.31% increase from fiscal 2023.
  • BRUKER CORPORATION inventory write-down for fiscal 2023 was $19.40M.
  • BRUKER CORPORATION inventory write-down for fiscal 2014 was $28.20M, a 13.76% decline from fiscal 2013.
Period endInventory Write-down 3 monthInventory Write-down 6 monthInventory Write-down 9 monthInventory Write-down 9 month as first filedInventory Write-down 12 monthInventory Write-down 12 month as first filed
2026-06-30$30.50M
10-Q · filed 2026-08-05
2025-12-31$76.00M
10-K · filed 2026-02-27
2025-06-30$23.80M
10-Q · filed 2026-08-05
2024-12-31$60.20M
10-K · filed 2026-02-27
2023-12-31$19.40M
10-K · filed 2026-02-27
2018-09-30$12.80M
10-Q · filed 2018-11-09
2017-09-30$9.50M
10-Q · filed 2018-11-09
2015-03-31$5.00M
10-Q · filed 2015-05-08
$10.60M
derived: sum of 2 quarters · filed 2015-05-08
$18.00M
derived: sum of 3 quarters · filed 2015-05-08
$25.60M
derived: sum of 4 quarters · filed 2015-05-08
2014-12-31$5.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$13.00M
derived: sum of 2 quarters · filed 2015-02-27
$20.60M
derived: sum of 3 quarters · filed 2015-02-27
$28.20M
10-K · filed 2015-02-27
2014-09-30$7.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$15.00M
derived: sum of 2 quarters · filed 2014-11-07
$22.60M
10-Q · filed 2014-11-07
$31.30M
derived: sum of 4 quarters · filed 2015-05-08
2014-06-30$7.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$15.20M
10-Q · filed 2014-08-08
$23.90M
derived: sum of 3 quarters · filed 2015-05-08
$31.90M
derived: sum of 4 quarters · filed 2015-05-08
2014-03-31$7.60M
10-Q · filed 2015-05-08
$16.30M
derived: sum of 2 quarters · filed 2015-05-08
$24.30M
derived: sum of 3 quarters · filed 2015-05-08
$32.50M
derived: sum of 4 quarters · filed 2015-05-08
2013-12-31$8.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$16.70M
derived: sum of 2 quarters · filed 2015-02-27
$24.90M
derived: sum of 3 quarters · filed 2015-02-27
$32.70M
10-K · filed 2015-02-27
2013-09-30$8.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$16.20M
derived: sum of 2 quarters · filed 2014-11-07
$24.00M
10-Q · filed 2014-11-07
$32.90M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$8.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$16.00M
10-Q · filed 2014-08-08
$24.90M
derived: sum of 3 quarters · filed 2015-02-27
$33.40M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$7.80M
10-Q · filed 2014-05-09
$16.70M
derived: sum of 2 quarters · filed 2015-02-27
$25.20M
derived: sum of 3 quarters · filed 2015-02-27
$32.50M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$8.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$17.40M
derived: sum of 2 quarters · filed 2015-02-27
$24.70M
derived: sum of 3 quarters · filed 2015-02-27
$31.50M
10-K · filed 2015-02-27
2012-09-30$8.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$15.80M
derived: sum of 2 quarters · filed 2013-11-08
$22.60M
10-Q · filed 2013-11-08
$30.60M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$7.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$14.10M
10-Q · filed 2013-08-08
$22.10M
derived: sum of 3 quarters · filed 2014-02-27
$30.50M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$6.80M
10-Q · filed 2013-05-09
$14.80M
derived: sum of 2 quarters · filed 2014-02-27
$23.20M
derived: sum of 3 quarters · filed 2014-02-27
$30.30M
derived: sum of 4 quarters · filed 2014-02-27
2011-12-31$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27
$16.40M
derived: sum of 2 quarters · filed 2014-02-27
$23.50M
derived: sum of 3 quarters · filed 2014-02-27
$30.00M
10-K · filed 2014-02-27
$38.40M
10-K · filed 2012-02-29
2011-09-30$8.40M
10-Q · filed 2011-11-09
$15.50M
derived: sum of 2 quarters · filed 2011-11-09
$22.00M
10-Q · filed 2012-11-08
$30.40M
10-Q · filed 2011-11-09
$25.70M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$7.10M
10-Q · filed 2011-08-09
$19.40M
10-Q · filed 2012-08-09
$17.30M
derived: sum of 3 quarters · filed 2013-02-28
$23.30M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$6.50M
10-Q · filed 2012-05-09
$10.20M
derived: sum of 2 quarters · filed 2013-02-28
$16.20M
derived: sum of 3 quarters · filed 2013-02-28
$21.80M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$3.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$9.70M
derived: sum of 2 quarters · filed 2013-02-28
$15.30M
derived: sum of 3 quarters · filed 2013-02-28
$24.40M
10-K · filed 2013-02-28
2010-09-30$6.00M
10-Q · filed 2011-11-09
$11.60M
derived: sum of 2 quarters · filed 2011-11-09
$20.70M
10-Q · filed 2011-11-09
2010-06-30$5.60M
10-Q · filed 2011-08-09
$11.20M
10-Q · filed 2011-08-09
2010-03-31$5.60M
10-Q · filed 2011-05-09
2009-12-31$26.10M
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avantor, Inc. (AVTR)United States$10.501B-9.72
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34